Skip to main content
. 2010 Nov 19;300(2):L225–L231. doi: 10.1152/ajplung.00264.2010

Fig. 4.

Fig. 4.

TNFR1 is elevated in the diaphragm following doxorubicin administration. A: TNFR1 mRNA (24 h: vehicle n = 6, treated n = 6; 48 h: vehicle n = 4, treated n = 8; 72 h: vehicle n = 7, treated n = 8). B: TNFR1 protein (24 h: vehicle n = 6, treated n = 6; 48 h: vehicle n = 5, treated n = 5; 72 h: vehicle n = 6, treated n = 6) in the diaphragm following doxorubicin administration. Data are % change of time-matched vehicles represented as means ± SE. For all panels, P < 0.05 for overall difference by repeated-measures ANOVA. A: *P < 0.05 (48 h); B: *P < 0.05 (55 kDa, 48 kDa) by Bonferroni test.